Astrana Health, Inc. (NASDAQ:ASTH) Holdings Decreased by Geode Capital Management LLC

Geode Capital Management LLC lessened its stake in Astrana Health, Inc. (NASDAQ:ASTH) by 0.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,016,775 shares of the company’s stock after selling 1,243 shares during the period. Geode Capital Management LLC’s holdings in Astrana Health were worth $32,066,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Premier Fund Managers Ltd boosted its holdings in shares of Astrana Health by 67.8% in the fourth quarter. Premier Fund Managers Ltd now owns 27,243 shares of the company’s stock valued at $871,000 after acquiring an additional 11,009 shares in the last quarter. Pictet Asset Management Holding SA lifted its position in Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company’s stock worth $223,000 after purchasing an additional 1,273 shares during the period. JPMorgan Chase & Co. boosted its stake in Astrana Health by 136.1% during the 4th quarter. JPMorgan Chase & Co. now owns 163,532 shares of the company’s stock valued at $5,156,000 after purchasing an additional 94,268 shares in the last quarter. Vanguard Group Inc. boosted its stake in Astrana Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company’s stock valued at $147,748,000 after purchasing an additional 20,757 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Astrana Health during the 4th quarter valued at $318,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Down 3.1 %

Shares of NASDAQ:ASTH opened at $32.70 on Thursday. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market cap of $1.64 billion, a PE ratio of 25.15, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04. The firm has a 50 day simple moving average of $32.25 and a 200 day simple moving average of $39.67.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ASTH. Stifel Nicolaus decreased their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Truist Financial reduced their price objective on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Robert W. Baird cut their target price on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Barclays started coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 target price for the company. Finally, Bank of America dropped their price target on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $53.29.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.